World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02623036
Date of registration: 19/11/2015
Prospective Registration: No
Primary sponsor: Memorial Health University Medical Center
Public title: The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors
Scientific title: The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors in Resistant Hypertension
Date of first enrolment: November 2015
Target sample size: 20
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT02623036
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  Phase 1
Countries of recruitment
United States
Contacts
Name:     John Bucheit, Pharm.D.
Address: 
Telephone: 312-350-8404
Email: bucheit_jd@mercer.edu
Affiliation: 
Name:     John D. Bucheit, Pharm D
Address: 
Telephone:
Email:
Affiliation:  Memorial Health University Medical Center
Name:     John D Bucheit, Pharm.D.
Address: 
Telephone: 912-350-8404
Email: bucheit_jd@mercer.edu
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients with clinic blood pressure > 140/90 mm Hg on 3 antihypertensives or clinic
blood pressure < 140/90 mm Hg on 4 antihypertensives

- Currently treated with an angiotensin converting enzyme inhibitor

Exclusion Criteria:

- Chronic kidney disease (CKD) stage 4 or worse

- Pheochromocytoma

- Unstable cardiovascular disease Stroke, Transient Ischemic Attack, Unstable Angina, or
Myocardial infarction in the last 30 days

- Hyperaldosteronism

- Current pregnancy

- Shift worker at night

- Presenting blood pressure > 180/110 mm Hg



Age minimum: 18 Years
Age maximum: 79 Years
Gender: All
Health Condition(s) or Problem(s) studied
Hypertension, Resistant to Conventional Therapy
Intervention(s)
Drug: Equivalent dose lisinopril
Drug: Equivalent dose enalapril
Primary Outcome(s)
Change from baseline nighttime blood pressure [Time Frame: Baseline and 4-6 weeks]
Secondary Outcome(s)
Change from baseline 24 Hour Blood Pressure [Time Frame: Baseline and 4-6 weeks]
Change from baseline night to day blood pressure ratio (dipping status) [Time Frame: Baseline and 4-6 weeks]
Secondary ID(s)
MHUMC 2015.10.01
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history